SREBF1 facilitates pathological retinal neovascularization by reprogramming the fatty acid metabolism of endothelial cells
Experimental Eye Research · 2025
DOI: 10.1016/j.exer.2025.110239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Eye Research, 2025. Verfasst von Hangjia Zuo und 7 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Prevention and Treatment on Major Blinding Diseases, Chong…. Hauptthemen laut MEDLINE: Retinal Neovascularization, Endothelial Cells, Retinopathy of Prematurity, Fatty Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Retinopathy of prematurity (ROP) is a proliferative retinal vascular disorder that critically affects the visual development of premature infants, potentially leading to irreversible vision loss or even blindness. Despite its significance, the underlying mechanisms of this disease remain insufficiently understood. In this study, we utilized the oxygen-induced retinopathy (OIR) mouse model and conducted endothelial functional assays to explore the role of Sterol Regulatory Element-Binding Protein 1 (SREBF1) in ROP pathogenesis. SREBF1 expression levels, along with its downstream targets, were investigated through Western blotting, RT-qPCR, and immunofluorescence staining techniques. Furthermore, Co-Immunoprecipitation (Co-IP) was employed to examine the molecular mechanisms involved. Our results demonstrated a significant increase in SREBF1 expression in both the OIR mouse model and hypoxic primary human retinal microvascular endothelial cells (HRMECs). Interventions conducted both in vivo and in vitro showed notable efficacy in reducing pathological neovascularization. Importantly, we discovered that SREBF1 plays a key role in modulating lipid metabolism in HRMECs by regulating the expression of ACC1 and FASN, leading to cellular reprogramming. This reprogramming influences HRMEC proliferation, migration, and tube formation through the HIF-1α/TGF-β signaling pathway, ultimately contributing to pathological retinal neovascularization. These findings provide new insights into the role of SREBF1 in angiogenesis within the context of ROP, offering potential therapeutic targets for the management and treatment of this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Prevention and Treatment on Major Blinding Diseases, Chongqing Eye Institute, Chongqing Branch (Municipality Division) of Nation…
- Chongqing Medical University, Chongqing, PR China.
- Chongqing Medical University, Chongqing, PR China; Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Labora…
Zitieren
APA
Zuo, H., Liu, X., Wang, Y., Ding, H., Wan, W., Zheng, S., Hou, S., & Hu, K. (2025). SREBF1 facilitates pathological retinal neovascularization by reprogramming the fatty acid metabolism of endothelial cells. Experimental Eye Research. https://doi.org/10.1016/j.exer.2025.110239
Vancouver
Zuo H, Liu X, Wang Y, Ding H, Wan W, Zheng S, et al. SREBF1 facilitates pathological retinal neovascularization by reprogramming the fatty acid metabolism of endothelial cells. Experimental Eye Research. 2025. doi:10.1016/j.exer.2025.110239
BibTeX
@article{Zuo2025,
author = {Zuo, Hangjia and Liu, Xianyang and Wang, Yakun and Ding, Huannan and Wan, Wenjuan and Zheng, Shijie and Hou, Shengping and Hu, Ke},
title = {SREBF1 facilitates pathological retinal neovascularization by reprogramming the fatty acid metabolism of endothelial cells},
journal = {Experimental Eye Research},
year = {2025},
doi = {10.1016/j.exer.2025.110239}
}
EUVIMED